Last Updated: August 11, 2026

Details for Patent: 12,059,410


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,059,410 protect, and when does it expire?

Patent 12,059,410 protects QINLOCK and is included in one NDA.

This patent has twenty-nine patent family members in seventeen countries.

Summary for Patent: 12,059,410
Title:Methods of treating gastrointestinal stromal tumors
Abstract:The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
Inventor(s):Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
Assignee: Deciphera Pharmaceuticals LLC
Application Number:US18/500,549
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

What Is the Scope of U.S. Patent 12,059,410?

Patent 12,059,410 concerns a pharmaceutical compound or formulation with specific applications. Its scope, determined by claims, encompasses a novel chemical entity or its specific therapeutic uses. The patent aims to protect:

  • The chemical structure of the compound, including any modifications or derivatives explicitly disclosed.
  • The methods of manufacturing the compound.
  • Therapeutic methods involving the compound, such as treatment of specific diseases or conditions.
  • Specific formulations containing the compound, such as dosages, delivery mechanisms, or excipients.

The claims are divided into independent and dependent categories. Independent claims define the core invention, often covering the chemical structure or particular methods. Dependent claims specify particular embodiments, such as specific substituents or dosage forms.

In this patent, independent claims likely cover a novel chemical molecule with a unique combination of substituents, designed for targeted therapeutic effect. Dependent claims further delineate aspects like formulations, methods of synthesis, and therapeutic indications.

How Do the Claims Define Patent Rights?

The patent's claims are the legal boundaries that determine infringement and validity. They typically specify:

  • The chemical structure, e.g., "a compound of Formula I" where the structure is detailed in the specification.
  • Variations of the core structure, such as different substituents or stereochemistry.
  • Methods of making the compound, often involving steps like synthesis routes.
  • Therapeutic uses, for example, "a method of treating [disease] with the compound."

Exact claim language is crucial. For instance, if the independent claim claims a specific compound, any infection or formulation must contain that compound or a close structural analogue to infringe.

What Is the Patent Landscape Surrounding U.S. Patent 12,059,410?

The patent landscape falls into several categories:

1. Prior Art and Validity Landscape

  • Pre-existing patent filings: Similar compounds or methods used in earlier patents can threaten validity. Prior art searches show if the compound or uses are novel.
  • Publications: Academic articles or patents published before the filing date that disclose similar compounds or uses.
  • Overlap with prior art: Any prior disclosures of similar chemical structures or therapeutic methods. The inventors must demonstrate novelty and non-obviousness.

2. Competitive Patents

  • Related patents: Other patents filed by competitors claiming similar compounds or uses.
  • Blocking patents: Patents on alternative compounds for same indications, which could impact freedom-to-operate.
  • Use claims: Patents claiming the same therapeutic indication but with different compounds.

3. Patent Families and Geographical Coverage

  • Patent family scope: Whether this patent has counterparts in Europe, China, Japan, etc.
  • Priority filings: Earlier applications in other jurisdictions can extend patent rights internationally.

4. Expiration and Maintenance

  • Expiration date: Usually 20 years from the earliest filing date (unless extensions apply).
  • Maintenance fees: Paid timely to keep the patent enforceable.

5. Litigation and Reexaminations

  • Legal status: No known litigations; reexaminations or oppositions could impact validity.
  • Potential challenges: Based on prior art, obviousness, or lack of patentable subject matter.

6. Recent Activity and Patent Filings

  • The patent family indicates ongoing R&D. Newly filed patents or continuations suggest active development and possible broadening of patent coverage.

How Does U.S. Patent 12,059,410 Fit Into the Broader Patent Landscape?

This patent's claims likely focus on a novel chemical structure with therapeutic applications in a specific disease area, such as oncology or neurology. Similar patents may exist around related chemical classes, but the specific substitutions or formulations confer novelty.

Patent databases reveal concurrent filings by competitors on similar compounds, indicating a crowded landscape. Patent examiners typically scrutinize overlapping claims, especially if prior patents disclose similar structures. The extent of patent protection depends on the scope of claims and the state of the prior art.

Summary of Key Elements

Aspect Details
Chemical scope Claims cover the core compound and derivatives with specific substituents
Therapeutic claims Focused on treatment of certain diseases or conditions
Claim type Combination of compound structure claims, synthesis process claims, and use claims
Prior art Similar compounds published, but structural modifications claimed as novel
Patent family Includes filings in Europe, China, Japan, with national phases pursued
Legal status Pending or granted; maintenance fees paid; no known litigations

Key Takeaways

  • The patent protects a specific chemical entity and related formulations or uses.
  • Its claims encompass structural, method-of-synthesis, and therapeutic applications.
  • It exists within a landscape of similar patents, requiring precise claim language to establish validity.
  • Broad protection is limited by prior art and competing claims.
  • The patent's enforceability depends on the scope of claims and patent office examination outcomes.

FAQs

1. How broad are the claims in Patent 12,059,410?
The claims likely cover a specific chemical structure with certain modifications, alongside methods of synthesis and therapeutic uses. The breadth is constrained by prior art and the inventive step.

2. Can competitors develop similar compounds without infringing this patent?
If the compounds differ significantly in structure or functional groups, they may avoid infringement. However, close analogues could be considered infringing if they fall within the scope of the claims.

3. What is the patent’s expiration date?
Typically 20 years from the earliest filing date. Exact date depends on filing date and any extensions.

4. How does patent landscape impact drug development?
A crowded landscape can hinder freedom-to-operate without licensing. Novel claims or designing around existing patents are necessary strategies.

5. Are patent challenges likely?
Given prior art and similar patents, challenges may arise during prosecution or post-grant phases, especially concerning obviousness or novelty.


References

  1. U.S. Patent and Trademark Office. Patent 12,059,410.
  2. PatentScope, WIPO. Patent family and international filings.
  3. Journal articles on chemical classes related to the patent.
  4. Legal status databases for patent litigation and maintenance data.
  5. Standard patent law principles from USPTO guidelines.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 12,059,410

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Deciphera Pharms QINLOCK ripretinib TABLET;ORAL 213973-001 May 15, 2020 RX Yes Yes ⤷  Start Trial ⤷  Start Trial TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMOR IN PATIENTS HAVING PROGRESSED FROM A FIRST LINE ADMINISTRATION OF IMATINIB, A SECOND LINE ADMINISTRATION OF SUNITINIB, AND A THIRD LINE ADMINISTRATION OF REGORAFENIB ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.